Boston Scientific ENDOTAK RELIANCE¿ SG, transvenous defibrillation lead, Models 0180 & 0292, Ster...

FDA Device Recall #Z-2147-2014 — Class II — June 19, 2014

Recall Summary

Recall Number Z-2147-2014
Classification Class II — Moderate risk
Date Initiated June 19, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Boston Scientific CRM Corp
Location Saint Paul, MN
Product Type Devices
Quantity 21

Product Description

Boston Scientific ENDOTAK RELIANCE¿ SG, transvenous defibrillation lead, Models 0180 & 0292, Sterile EO. Product Usage: The ENDOTAK RELIANCE leads provide pacing and rate-sensing and deliver cardioversion and defibrillation shocks for automatic implantable cardioverter defibrillator (AICD) systems.

Reason for Recall

A review of manufacturing test records for Boston Scientific ENDOTAK RELIANCE implantable leads revealed a suspected test data recording error. Specifically, some test results were recorded as "failed" without any other indication of failure. There are no reported injuries from the devices.

Distribution Pattern

Worldwide Distribution -US (nationwide) in the states of OH, MN and country of France

Lot / Code Information

Model 0180 s/n 310735 & 310892. Model 0292 s/n 130450, & 309339.

Other Recalls from Boston Scientific CRM Corp

Recall # Classification Product Date
Z-0087-2015 Class II Boston Scientific COGNIS CRT-D, Cardiac Resynch... Sep 17, 2014
Z-0088-2015 Class II Boston Scientific TELIGEN, Implantable Cardiac ... Sep 17, 2014
Z-0026-2014 Class II Boston Scientific TELIGEN, Implantable Cardiac ... Aug 29, 2013
Z-0025-2014 Class II Boston Scientific COGNIS CRT-D, Cardiac Resynch... Aug 29, 2013
Z-1979-2013 Class II Boston Scientific, ENERGEN DR ICD, Model E143. ... Jul 15, 2013

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.